Merger Notification - Announcement according to § 10 Cartel Act
Clayton Dubilier & Rice, LLC; UDG Healthcare plc
BWB/Z-5447
On 04.06.2021 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Clayton Dubilier & Rice, LLC, USA, intends to acquire indirectly via a special purpose vehicle, i.e. Nenelite Limited, Ireland, all issued and to be issued shares in and sole control over UDG Healthcare plc, Ireland.
The Target is a provider of healthcare advisory, marketing, communications, strategic engagement and patient services to leading pharmaceutical, biotech and specialty companies.
UDG also offers contract packaging, clinical manufacturing and trial manufacturing.
ÖNACE Code: M 70.2 Public-Relations and Business Consultancy Services.
Industry sector: M - Erbringung von freiberuflichen, wissenschaftlichen und technischen Dienstleistungen
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 02.07.2021.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 03.07.2021 .